{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:06:37Z","timestamp":1791299197832,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although horizontal gene transfer plays a pivotal role in bacteriophage evolution, many lytic phage genomes are clearly shaped by vertical evolution. We investigated the influence of minor genomic deletions and insertions on various phage-related phenotypic and serological properties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>\n                      We collected ten different isolates of\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      bacteriophage \u03d5KMV. All sequenced genomes (42-43 kb, long direct terminal repeats) are nearly identical, which intuitively implied strongly similar infections cycles. However, their latent periods vary between 21 and 28 minutes and they are able to lyse between 5 and 58% of a collection of 107 clinical\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      strains. We also noted that phages with identical tail structures displayed profound differences in host spectra. Moreover, point mutations in tail and spike proteins were sufficient to evade neutralization by two phage-specific antisera, isolated from rabbits.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although all analyzed phages are 83-97% identical at the genome level, they display a surprisingly large variation in various phenotypic properties. The small overlap in host spectrum and their ability to readily escape immune defences against a nearly identical phage are promising elements for the application of these phages in phage therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1743-422x-8-134","type":"journal-article","created":{"date-parts":[[2011,3,23]],"date-time":"2011-03-23T15:17:56Z","timestamp":1300893476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Phenotypic and genotypic variations within a single bacteriophage species"],"prefix":"10.1186","volume":"8","author":[{"given":"Pieter-Jan","family":"Ceyssens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Glonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ndrew M","family":"Kropinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Chanishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Kulakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Lashkhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Tediashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Merabishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,23]]},"reference":[{"key":"1247_CR1","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.drudis.2009.03.006","volume":"14","author":"JN Housby","year":"2009","unstructured":"Housby JN, Mann NH: Phage therapy. Drug Discov Today. 2009, 14: 536-540. 10.1016\/j.drudis.2009.03.006.","journal-title":"Drug Discov Today"},{"key":"1247_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ijmm.2010.04.002","volume":"300","author":"VA Fischetti","year":"2010","unstructured":"Fischetti VA: Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. Int J Med Microbiol. 2010, 300: 357-362. 10.1016\/j.ijmm.2010.04.002.","journal-title":"Int J Med Microbiol"},{"key":"1247_CR3","first-page":"766","volume":"10","author":"A G\u00f3rski","year":"2009","unstructured":"G\u00f3rski A, Miedzybrodzki R, Borysowski J, Weber-Dabrowska B, Lobocka M, Fortuna W, Letkiewicz S, Zimecki M, Filby G: Bacteriophage therapy for the treatment of infections. Curr Opin Investig Drugs. 2009, 10: 766-774.","journal-title":"Curr Opin Investig Drugs"},{"key":"1247_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1749-4486.2009.01973.x","volume":"34","author":"A Wright","year":"2009","unstructured":"Wright A, Hawkins CH, Angg\u00e5rd EE, Harper DR: A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol. 2009, 34: 349-357. 10.1111\/j.1749-4486.2009.01973.x.","journal-title":"Clin Otolaryngol"},{"key":"1247_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.12968\/jowc.2009.18.6.42801","volume":"18","author":"DD Rhoads","year":"2009","unstructured":"Rhoads DD, Wolcott RD, Kuskowski MA, Wolcott BM, Ward LS, Sulakvelidze A: Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J Wound Care. 2009, 18: 237-238.","journal-title":"J Wound Care"},{"key":"1247_CR6","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1086\/597405","volume":"48","author":"S Deresinski","year":"2009","unstructured":"Deresinski S: Bacteriophage therapy: exploiting smaller fleas. Clin Infect Dis. 2009, 48: 1096-1101. 10.1086\/597405.","journal-title":"Clin Infect Dis"},{"key":"1247_CR7","doi-asserted-by":"crossref","unstructured":"Loc-Carrillo C, Abedon ST: Pros and cons of phage therapy. Bacteriophage. 1: 1-4.","DOI":"10.4161\/bact.1.2.14590"},{"key":"1247_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.resmic.2008.04.005","volume":"159","author":"SR Casjens","year":"2008","unstructured":"Casjens SR: Diversity among the tailed-bacteriophages that infect the Enterobacteriaceae. Res Microbiol. 2008, 159: 340-348. 10.1016\/j.resmic.2008.04.005.","journal-title":"Res Microbiol"},{"key":"1247_CR9","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2217\/fmb.10.66","volume":"5","author":"PJ Ceyssens","year":"2010","unstructured":"Ceyssens PJ, Lavigne R: Bacteriophages of Pseudomonas. Future Microbiol. 2010, 5: 1041-1055. 10.2217\/fmb.10.66.","journal-title":"Future Microbiol"},{"key":"1247_CR10","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.12.077","volume":"377","author":"D Savalia","year":"2008","unstructured":"Savalia D, Westblade LF, Goel M, Florens L, Kemp P, Akulenko N, Pavlova O, Padovan JC, Chait BT, Washburn MP, Ackermann HW, Mushegian A, Gabisonia T, Molineux I, Severinov K: Genomic and proteomic analysis of phiEco32, a novel Escherichia coli bacteriophage. J Mol Biol. 2008, 377: 774-789. 10.1016\/j.jmb.2007.12.077.","journal-title":"J Mol Biol"},{"key":"1247_CR11","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1111\/j.1462-2920.2009.02021.x","volume":"11","author":"F Angly","year":"2009","unstructured":"Angly F, Youle M, Nosrat B, Srinagesh S, Rodriguez-Brito B, McNairnie P, Deyanat-Yazdi G, Breitbart M, Rohwer F: Genomic analysis of multiple Roseophage SIO1 strains. Environ Microbiol. 2009, 11: 2863-2873. 10.1111\/j.1462-2920.2009.02021.x.","journal-title":"Environ Microbiol"},{"key":"1247_CR12","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/j.1462-2920.2008.01862.x","volume":"11","author":"PJ Ceyssens","year":"2009","unstructured":"Ceyssens PJ, Noben JP, Ackermann HW, Verhaegen J, De Vos D, Pirnay JP, Merabishvili M, Vaneechoutte M, Chibeu A, Volckaert G, Lavigne R: Survey of Pseudomonas aeruginosa and its phages: de novo peptide sequencing as a novel tool to assess the diversity of worldwide collected viruses. Environ Microbiol. 2009, 11: 1303-1313. 10.1111\/j.1462-2920.2008.01862.x.","journal-title":"Environ Microbiol"},{"key":"1247_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0042-6822(03)00123-5","volume":"312","author":"R Lavigne","year":"2003","unstructured":"Lavigne R, Burkal'tseva MV, Robben J, Sykilinda NN, Kurochkina LP, Jonckx B, Grymonprez B, Krylov VN, Mesyanzhinov VV, Volckaert G: The genome of bacteriophage \u03d5KMV, a T7-like virus infecting Pseudomonas aeruginosa. Virology. 2003, 312: 49-59. 10.1016\/S0042-6822(03)00123-5.","journal-title":"Virology"},{"key":"1247_CR14","doi-asserted-by":"publisher","first-page":"6924","DOI":"10.1128\/JB.00831-06","volume":"188","author":"PJ Ceyssens","year":"2006","unstructured":"Ceyssens PJ, Lavigne R, Mattheus W, Chibeu A, Hertveldt K, Mast J, Robben J, Volckaert G: Genomic analysis of Pseudomonas aeruginosa phages LKD16 and LKA1: establishment of the \u03d5KMV subgroup within the T7 supergroup. J Bacteriol. 2006, 188: 6924-6931. 10.1128\/JB.00831-06.","journal-title":"J Bacteriol"},{"key":"1247_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.mimet.2009.02.006","volume":"77","author":"E Lammens","year":"2009","unstructured":"Lammens E, Ceyssens PJ, Voet M, Hertveldt K, Lavigne R, Volckaert G: Representational Difference Analysis (RDA) of bacteriophage genomes. J Microbiol Methods. 2009, 77: 207-213. 10.1016\/j.mimet.2009.02.006.","journal-title":"J Microbiol Methods"},{"key":"1247_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2009.06.024","volume":"391","author":"LA Kulakov","year":"2009","unstructured":"Kulakov LA, Ksenzenko VN, Shlyapnikov MG, Kochetkov VV, Del Casale A, Allen CC, Larkin MJ, Ceyssens PJ, Lavigne R: Genomes of \"phiKMV-like viruses\" of Pseudomonas aeruginosa contain localized single-strand interruptions. Virology. 2009, 391: 1-4. 10.1016\/j.virol.2009.06.024.","journal-title":"Virology"},{"key":"1247_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1365-2672.2009.04469.x","volume":"108","author":"T Glonti","year":"2010","unstructured":"Glonti T, Chanishvili N, Taylor PW: Bacteriophage-derived enzyme that depolymerases the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa. J Appl Microbiol. 2010, 108: 695-702. 10.1111\/j.1365-2672.2009.04469.x.","journal-title":"J Appl Microbiol"},{"key":"1247_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-1-60327-164-6_24","volume":"501","author":"TE Waddell","year":"2009","unstructured":"Waddell TE, Franklin K, Mazzocco A, Johnson RP: Preparation and characterization of anti-phage serum. Methods Mol Biol. 2009, 501: 287-292. full_text.","journal-title":"Methods Mol Biol"},{"key":"1247_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev.micro.112408.134123","volume":"64","author":"H Deveau","year":"2010","unstructured":"Deveau H, Garneau JE, Moineau S: CRISPR\/Cas system and its role in phage-bacteria interactions. Annu Rev Microbiol. 2010, 64: 475-493. 10.1146\/annurev.micro.112408.134123.","journal-title":"Annu Rev Microbiol"},{"key":"1247_CR20","doi-asserted-by":"crossref","unstructured":"Cady KC, White AS, Hammond JH, Abendroth MD, Karthikeyan RS, Prajna L, Zegans ME, O'Toole GA: Prevalence, conservation and functional analysis of Yersinia and Escherichia CRISPR regions in clinical Pseudomonas aeruginosa Isolates. Microbiology. 157: 430-437. 10.1099\/mic.0.045732-0.","DOI":"10.1099\/mic.0.045732-0"},{"key":"1247_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrmicro2315","volume":"8","author":"SJ Labrie","year":"2010","unstructured":"Labrie SJ, Samson JE, Moineau S: Bacteriophage resistance mechanisms. Nat Rev Microbiol. 2010, 8: 317-327. 10.1038\/nrmicro2315.","journal-title":"Nat Rev Microbiol"},{"key":"1247_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.virusres.2005.05.014","volume":"114","author":"CL Vitiello","year":"2005","unstructured":"Vitiello CL, Merril CR, Adhya S: An amino acid substitution in a capsid protein enhances phage survival in mouse circulatory system more than a 1000-fold. Virus Res. 2005, 114: 101-103. 10.1016\/j.virusres.2005.05.014.","journal-title":"Virus Res"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T09:40:09Z","timestamp":1630489209000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,23]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1247"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-134","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,23]]},"assertion":[{"value":"19 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"134"}}